Marimed Inc
General ticker "MRMD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $51.8M
Marimed Inc does not follow the US Stock Market performance with the rate: -41.3%.
Estimated limits based on current volatility of 6.0%: low 0.11$, high 0.13$
Factors to consider:
- Current price 34.8% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.18$, 0.42$]
- 2024-12-30 to 2025-12-30 estimated range: [0.22$, 0.49$]
Financial Metrics affecting the MRMD estimates:
- Negative: Non-GAAP EPS, $ of -0.04 <= 0.10
- Negative: negative Net income
- Positive: 9.05 < Operating profit margin, % of 9.68
- Positive: Interest expense per share, $ of 0.03 <= 0.14
Short-term MRMD quotes
Long-term MRMD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $121.46MM | $134.01MM | $148.60MM |
| Operating Expenses | $94.60MM | $113.64MM | $134.21MM |
| Operating Income | $26.86MM | $20.37MM | $14.38MM |
| Non-Operating Income | $-3.05MM | $-0.86MM | $-20.98MM |
| Interest Expense | $2.36MM | $1.69MM | $9.19MM |
| Income(Loss) | $23.82MM | $19.51MM | $-6.60MM |
| Taxes | $16.19MM | $5.89MM | $9.41MM |
| Profit(Loss) | $7.62MM | $13.61MM | $-16.01MM |
| Stockholders Equity | $36.30MM | $57.31MM | $69.91MM |
| Inventory | $9.77MM | $19.48MM | $25.31MM |
| Assets | $123.20MM | $152.20MM | $196.12MM |
| Operating Cash Flow | $35.85MM | $7.31MM | $7.91MM |
| Capital expenditure | $18.57MM | $12.74MM | $20.13MM |
| Investing Cash Flow | $-16.62MM | $-26.24MM | $-25.98MM |
| Financing Cash Flow | $7.45MM | $-1.01MM | $22.98MM |
| Earnings Per Share* | $0.02 | $0.04 | $-0.04 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.